Therefore, future investigations are crucial in identifying whether neuroinflammatory agents, such as TNF-a, IL-6, or IL-1b, contribute to the association of stroke risk with RA and whether these agents are similarly influential in other inflammatory diseases, such as ankylosing spondylitis. Here, IL6 is linked to rheumatoid arthritis.